Journals / Van Tıp Dergisi / 2022 / Cilt: 29 - Sayı: 1

Diabetes Adversely Affects Respiratory Functions in Patients with COPD

Diyabet, KOAH’lı Hastalarda Solunum Fonksiyonlarını Kötü Yönde Etkiler

Pages
103–107
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: It has been found that diabetes can adversely affect respiratory parameters in patients with COPD, and more comprehensive studies are needed to show this relationship.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Chronic Obstructive Pulmonary Disease, cigarette smoking and exposure to biomass that can occur as a disease can affect all systems.
📊
Key Findings & Data:Increased morbidity and mortality in COPD patients with additional diseases.
💡
Conclusion & Impact:Conclusion: It has been found that diabetes can adversely affect respiratory parameters in patients with COPD, and more comprehensive studies are needed to show this relationship.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Introduction: Chronic Obstructive Pulmonary Disease, cigarette smoking and exposure to biomass that can occur as a disease can affect all systems. Increased morbidity and mortality in COPD patients with additional diseases. DM is a multisystemic disease affects all organs, it also affects the respiratory reproach. The main purpose of our study is due to diabetes patients with COPD-related lung function changes in spirometric evaluation. Methods: A total of 72 COPD cases were included in the study. Of these cases, 37 were COPD patients and 35 were COPD + DM patients. The cases were evaluated in two main groups, not to look for an ethyological cause. All patients were initially evaluated for taking history, physical examination, system inquiry, additional disease. COPD duration was recorded as years according to diagnosis or patients’ history, similarly DM patients were recorded as years according to diagnosis or patients’ history. Patients were tested for respiratory function. Spirometric values of both groups were compared. Results: 37 cases of COPD (51.4%) 35 cases of COPD + DM (48.6%) were present, although there was no statistical difference when the data were evaluated between the two groups determined in general, changes in respiratory function parameters were noticeable. Statistically significant differences were found in FEV1%, FVC%, FEV1/FVC ratio parameters in the evaluation by gender. There was a significant negative correlation between age (COPD and COPD + DM) and FEV1, FVC, FVC % ratios between the groups, and there was a significant pos itive correlation between age and COPD duration. There was a significant negative correlation between FEV1 and PCO2, COPD duration rates. Between FEV1% and COPD duration ratios, there was a significant negative correlation. Conclusion: It has been found that diabetes can adversely affect respiratory parameters in patients with COPD, and more comprehensive studies are needed to show this relationship.

Özet

Amaç: Kronik Obstrüktif Akciğer Hastalığı, sigara içimi ve biomass maruziyetine ba ğlı olarak gelişebilen ve tüm sistemleri etkileyebilen bir hastal ıktır. KOAH l ı hastalarda ek hastalıklar morbidite ve mortaliteyi arttırmaktadır. DM multisistemik bir hastalık olup tüm organları etkilediği gibi solunum sitemini de etkilemektedir. Çalışmamızın temel amac ı KOAH’lı hastaların diyabetten dolayı solunum fonksiyonlarındaki de ğişikliklerin spirometrik olarak değerlendirilmesidir. Yöntem ve Gereçler: Toplam 72 KOAH olgusu çalışmaya alındı. Bu olguların 37’si KOAH, 35’i KOAH + DM hastaları idi. Olgular etyolojik neden aranmaks ın iki ana grupta de ğerlendirildi. KOAH süresi tanı veya hasta anamnezine göre y ıl olarak kaydedildi, buna benzer şekilde DM hastaları da tan ı veya hasta anamnezine göre y ıl olarak kaydedildi. Hastalara solunum fonksiyon testi yap ıldı. Her iki grubun spirometrik değerleri karşılaştırıldı. Bulgular: 37 olgu KOAH (% 51.4) 35 olgu KOAH + DM (%48.6) mevcuttu, genel olarak belirlenen iki grup arasında veriler değerlendirildiğinde istatiksel olarak fark olmamasına ra ğmen solunum fonksiyon pa rametrelerindeki değişiklikler göze çarptı. Cinsiyete göre değerlendirmede ise FEV1%, FVC%, FEV1/FVC oranı parametrelerinde istatistiki olarak anlamlı farklar bulundu. Gruplar aras ında (KOAH ile KOAH + DM ) ya ş ile FEV1, FVC, FVC % oranları arasında anlamlı negatif korelasy on mevcuttu, yaş ile KOAH süresi arasında ise anlamlı pozitif korelasyon vardı. FEV1 ile PCO2, KOAH süresi oranları arasında anlamlı negatif korelasyon mevcuttu. FEV1% ile KOAH süresi oranları arasında ise anlamlı negatif korelasyon mevcuttu. Tartışma ve Sonuç: Diyabetin KOAH’lı hastalarda solunumsal parametreleri olumsuz yönde etkileyebileceği, bu ilişkiyi gösterebilmek için daha kapsamlı çalışmalara ihtiyaç duyulduğu sonucuna varılmıştır.

🔖

Cite This Article

Bilgin, M. H., Arısoy, A., Sertoğullarından, B. (2022). Diabetes Adversely Affects Respiratory Functions in Patients with COPD. Van Tıp Dergisi, Cilt: 29 - Sayı: 1, 103–107. https://ajindex.com/articles/645886

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Halpin D, Celli B, Criner G, Frith P, Varela L, Salvi S, et al. The GOLD Summit on chronic obstructive pulmonary disease in low-and middle-income countries. The International Journal of Tuberculosis and Lung Disease 2019;23(11):1131-1141
  2. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS medicine 2006;3(11):e442
  3. Global Strategy For The Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease, GOLD Report 2021
  4. Organization WH. The World health report: 2004: changing history: World Health Organization; 2004
  5. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. American jour nal of respiratory and critical care medicine 2007;176(6):532- 555
  6. Ekici A, Ekici M, Kurtipek E, Akin A, Arslan M, Kara T, et al. Obstructive airway diseases in women exposed to biomass smoke. Environmental Research 2005;99(1):93-98
  7. Braunwald E Kasper D, Fauci A, Hauser S, Longo D, Jameson J, et al. Harrison's principles of internal medicine 15edition:2003:s: 2109-2143
  8. Atlas D. International diabetes federation. IDF Diabetes Atlas, 7th edn Brussels, Belgium: International Diabetes Federation. 2015. Eur Respir J 2006; 27: 188-207
  9. Putcha N, Drummond MB, Wise RA, Hansel NN, editors. Comorbidities and chronic obstructive pulmonary disease: prevalence, influence on outcomes, and management. Seminars in respiratory and critical care medicine; 2015: NIH Public Access
  10. Kinney GL, Black-Shinn JL, Wan ES, Make B, Regan E, Lutz S, et al. Pulmonary function reduction in diabetes with and without chronic obstructive pulmonary disease. Diabetes care 2014;37(2):389-395
  11. Mamillapalli C, Tentu R, Jain NK, Bhandari R. COPD and type 2 diabetes. Current Respiratory Medicine Reviews 2019;15(2):112-119
  12. Shah SH, Sonawane P, Nahar P, Vaidya S, Salvi S. Pulmonary function tests in type 2 diabetes mellitus and their association with glycemic control and duration of the disease. Lung India: Official Organ of Indian Chest Society 2013;30(2):108-112
  13. Franssen F, O’Donnell D, Goossens G, Blaak E, Schols A. Obesity and the lung: 5· Obesity and COPD. Thorax 2008;63(12):1110-1117
  14. Collins LC, Hoberty PD, Walker JF, Fletcher EC, Peiris AN. The effect of body fat distribution on pulmonary function tests Chest 1995;107(5):1298-1302
  15. Bolton C, Evans M, Ione